ARBs from India Safe; Aspirin Primary Prevention; Energy Pill Risk
Recent developments of interest in cardiovascular medicine
The FDA's inspection of a number of plants in India that make the active pharmaceutical ingredients for valsartan, losartan, and irbesartan turned up none of the cancer-related NDMA (N-Nitrosodimethylamine) contaminant that has led to recent recalls from other companies. (in-Pharma Technologist.com)